Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients
Background. Glioma is the most common primary brain tumor with high mortality and poor outcomes. As a hallmark of cancers, inflammatory responses are crucial for their progression. The present study is aimed at exploring the prognostic value of inflammatory response-related genes (IRRGs) and constru...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/8972730 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565314516156416 |
|---|---|
| author | Zhaoyue Yan Yushuai Gao Jinliang Yu Zhiyuan Shen Xingyao Bu |
| author_facet | Zhaoyue Yan Yushuai Gao Jinliang Yu Zhiyuan Shen Xingyao Bu |
| author_sort | Zhaoyue Yan |
| collection | DOAJ |
| description | Background. Glioma is the most common primary brain tumor with high mortality and poor outcomes. As a hallmark of cancers, inflammatory responses are crucial for their progression. The present study is aimed at exploring the prognostic value of inflammatory response-related genes (IRRGs) and constructing a prognostic IRRG signature for gliomas. Materials and Methods. We investigated the relationship between IRRGs and gliomas by integrating the transcriptomic data for gliomas from public databases. Differentially expressed IRRGs (DE-IRRGs) were identified in the GSE4290 cohort. Further, univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses were conducted to construct an IRRG signature using The Cancer Genome Atlas (TCGA) cohort. Gliomas from the Chinese Glioma Genome Atlas (CGGA) cohort were employed for independent validation. The performance of gene signature was assessed by survival and receiver operating characteristic curve analyses. The differences in clinical correlations, immune infiltrate types, immunotherapeutic response predictions, and pathway enrichment among subgroups were investigated via bioinformatic algorithms. Results. In total, 37 DE-IRRGs were determined, of which 31 were found to be associated with survival. Ultimately, eight genes were retained to construct an IRRG signature that further classified glioma patients into two groups; the high-risk group suffered a poorer outcome as compared to the low-risk group. Furthermore, the high-risk group was significantly correlated with several risk factors, including older age, higher tumor grade, IDH wild type, 1p19q noncodel, and MGMT unmethylation. The nomogram was constructed by integrating the risk scores and other independent clinical characteristics. Moreover, the high-risk group had a greater immune infiltration and was most likely to benefit from immunotherapy. Gene set enrichment analysis suggested that immune and oncogenic pathways were enriched in high-risk glioma patients. Conclusion. We constructed a signature composed of eight IRRGs for gliomas, which could effectively predict survival and guide decision-making for treatment. |
| format | Article |
| id | doaj-art-860e8734d6cd418db0b6a61a6233eeb5 |
| institution | Kabale University |
| issn | 2314-7156 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-860e8734d6cd418db0b6a61a6233eeb52025-02-03T01:08:45ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/8972730Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma PatientsZhaoyue Yan0Yushuai Gao1Jinliang Yu2Zhiyuan Shen3Xingyao Bu4Department of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryBackground. Glioma is the most common primary brain tumor with high mortality and poor outcomes. As a hallmark of cancers, inflammatory responses are crucial for their progression. The present study is aimed at exploring the prognostic value of inflammatory response-related genes (IRRGs) and constructing a prognostic IRRG signature for gliomas. Materials and Methods. We investigated the relationship between IRRGs and gliomas by integrating the transcriptomic data for gliomas from public databases. Differentially expressed IRRGs (DE-IRRGs) were identified in the GSE4290 cohort. Further, univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses were conducted to construct an IRRG signature using The Cancer Genome Atlas (TCGA) cohort. Gliomas from the Chinese Glioma Genome Atlas (CGGA) cohort were employed for independent validation. The performance of gene signature was assessed by survival and receiver operating characteristic curve analyses. The differences in clinical correlations, immune infiltrate types, immunotherapeutic response predictions, and pathway enrichment among subgroups were investigated via bioinformatic algorithms. Results. In total, 37 DE-IRRGs were determined, of which 31 were found to be associated with survival. Ultimately, eight genes were retained to construct an IRRG signature that further classified glioma patients into two groups; the high-risk group suffered a poorer outcome as compared to the low-risk group. Furthermore, the high-risk group was significantly correlated with several risk factors, including older age, higher tumor grade, IDH wild type, 1p19q noncodel, and MGMT unmethylation. The nomogram was constructed by integrating the risk scores and other independent clinical characteristics. Moreover, the high-risk group had a greater immune infiltration and was most likely to benefit from immunotherapy. Gene set enrichment analysis suggested that immune and oncogenic pathways were enriched in high-risk glioma patients. Conclusion. We constructed a signature composed of eight IRRGs for gliomas, which could effectively predict survival and guide decision-making for treatment.http://dx.doi.org/10.1155/2022/8972730 |
| spellingShingle | Zhaoyue Yan Yushuai Gao Jinliang Yu Zhiyuan Shen Xingyao Bu Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients Journal of Immunology Research |
| title | Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients |
| title_full | Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients |
| title_fullStr | Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients |
| title_full_unstemmed | Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients |
| title_short | Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients |
| title_sort | identification of an inflammatory response related gene signature to predict survival and immune status in glioma patients |
| url | http://dx.doi.org/10.1155/2022/8972730 |
| work_keys_str_mv | AT zhaoyueyan identificationofaninflammatoryresponserelatedgenesignaturetopredictsurvivalandimmunestatusingliomapatients AT yushuaigao identificationofaninflammatoryresponserelatedgenesignaturetopredictsurvivalandimmunestatusingliomapatients AT jinliangyu identificationofaninflammatoryresponserelatedgenesignaturetopredictsurvivalandimmunestatusingliomapatients AT zhiyuanshen identificationofaninflammatoryresponserelatedgenesignaturetopredictsurvivalandimmunestatusingliomapatients AT xingyaobu identificationofaninflammatoryresponserelatedgenesignaturetopredictsurvivalandimmunestatusingliomapatients |